Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of Patients With COVID-19.
NCT ID: NCT05107245
Last Updated: 2021-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
143 participants
OBSERVATIONAL
2020-04-28
2021-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19 patients
Hospitalised COVID-19 patients
1test1
Loss of bacterial diversity diagnosis
Controls
Exposed medical staff
1test1
Loss of bacterial diversity diagnosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1test1
Loss of bacterial diversity diagnosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Control subjects: Medical and paramedical personnel working at one of the investigating sites, having been in direct contact with the patients.
* Aged between 18 and 95 years.
* Subjects able to read the French-language study information leaflet.
* Patients with social cover.
Exclusion Criteria
* Patients in critical care, heart failure or respiratory failure.
* Unable to provide naturally a stool sample.
* Patients without social cover.
* Pregnant women
18 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinique Saint Jean Ermitage
UNKNOWN
Nantes University Hospital
OTHER
Centre Hospitalier de Fontainebleau
UNKNOWN
Clinique du Mousseau
UNKNOWN
Luxia Scientific
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire de Nantes
Nantes, Pays de la Loire Region, France
Centre Hospitalier de Fontainebleau
Fontainebleau, Seine-et-Marne, France
Clinique Saint Jean l'Ermitage
Melun, Seine-et-marne, France
Clinique du Mousseau
Évry-Courcouronnes, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A00979-30
Identifier Type: -
Identifier Source: org_study_id